Wikidata entity: Q412221
C₉H₉Cl₂N₃ (P274)
Quantities
| P4250 | defined daily dose | 0.1 |
| P2067 | mass | 229.017 |
| P3780 | active ingredient in | ... | Q47521381 (Kapvay) | Kapvay |
| P3780 | active ingredient in | ... | Q47521512 (Duraclon) | Duraclon |
| P3780 | active ingredient in | ... | Q48828096 (Catapres-TTS-3) | Catapres-TTS-3 |
| P3780 | active ingredient in | ... | Q48828854 (Catapres-TTS-2) | Catapres-TTS-2 |
| P3780 | active ingredient in | ... | Q48829285 (Catapres-TTS-1) | Catapres-TTS-1 |
| P233 | canonical SMILES | String | C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl | ??? |
| P373 | Commons category | String | Clonidine | ??? |
| P366 | has use | ... | Q12140 (medication) | medication |
| P8224 | image of molecular model or crystal lattice model | CommonsMedia | http://commons.wikimedia.org/wiki/Special:FilePath/Clonidine%20ball-and-stick%20model.png | ??? |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P3493 | legal status (medicine) | ... | Q879952 (boxed warning) | boxed warning |
| P8026 | LiverTox likelihood score | ... | Q83284667 (LiverTox toxicity likelihood category E) | LiverTox toxicity likelihood category E |
| P2175 | medical condition treated | ... | Q41861 (arterial hypertension) | arterial hypertension |
| P2175 | medical condition treated | ... | Q191779 (Tourette syndrome) | Tourette syndrome |
| P2175 | medical condition treated | ... | Q117060 (spasticity) | spasticity |
| P2175 | medical condition treated | ... | Q159701 (glaucoma) | glaucoma |
| P2175 | medical condition treated | ... | Q761862 (hypersalivation) | hypersalivation |
| P2175 | medical condition treated | ... | Q181923 (attention deficit hyperactivity disorder) | attention deficit hyperactivity disorder |
| P129 | physically interacts with | ... | Q4734891 (Adrenoceptor alpha 2C) | Adrenoceptor alpha 2C |
| P129 | physically interacts with | ... | Q4734892 (Adrenoceptor alpha 2A) | Adrenoceptor alpha 2A |
| P129 | physically interacts with | ... | Q21141045 (Adrenoceptor alpha 2B) | Adrenoceptor alpha 2B |
| P129 | physically interacts with | ... | Q21172213 (Solute carrier family 22 member 1) | Solute carrier family 22 member 1 |
| P129 | physically interacts with | ... | Q21982203 (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) | Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 |
| P129 | physically interacts with | ... | Q21982207 (Hyperpolarization-activated, cyclic nucleotide-gated K+ 2) | Hyperpolarization-activated, cyclic nucleotide-gated K+ 2 |
| P129 | physically interacts with | ... | Q21982210 (Hyperpolarization activated cyclic nucleotide gated potassium channel 1) | Hyperpolarization activated cyclic nucleotide gated potassium channel 1 |
| P3489 | pregnancy category | ... | Q3679234 (Australian pregnancy category B3) | Australian pregnancy category B3 |
| P3489 | pregnancy category | ... | Q28123617 (US pregnancy category C) | US pregnancy category C |
| P769 | significant drug interaction | ... | Q58376 (fluphenazine) | fluphenazine |
| P769 | significant drug interaction | ... | Q58396 (imipramine) | imipramine |
| P769 | significant drug interaction | ... | Q58397 (amitriptyline) | amitriptyline |
| P769 | significant drug interaction | ... | Q58614 (loxapine) | loxapine |
| P769 | significant drug interaction | ... | Q201872 (olanzapine) | olanzapine |
| P769 | significant drug interaction | ... | Q58713 (clomipramine) | clomipramine |
| P769 | significant drug interaction | ... | Q144085 (pimozide) | pimozide |
| P769 | significant drug interaction | ... | Q412443 (risperidone) | risperidone |
| P769 | significant drug interaction | ... | Q412515 (bisoprolol) | bisoprolol |
| P769 | significant drug interaction | ... | Q410291 (verapamil) | verapamil |
| P769 | significant drug interaction | ... | Q411325 (atenolol) | atenolol |
| P769 | significant drug interaction | ... | Q412534 (carvedilol) | carvedilol |
| P769 | significant drug interaction | ... | Q413591 (sotalol) | sotalol |
| P769 | significant drug interaction | ... | Q418101 (pindolol) | pindolol |
| P769 | significant drug interaction | ... | Q418130 (nebivolol) | nebivolol |
| P769 | significant drug interaction | ... | Q418139 (esmolol) | esmolol |
| P769 | significant drug interaction | ... | Q418857 (acebutolol) | acebutolol |
| P769 | significant drug interaction | ... | Q420586 (celiprolol) | celiprolol |
| P769 | significant drug interaction | ... | Q221361 (clozapine) | clozapine |
| P769 | significant drug interaction | ... | Q251347 (haloperidol) | haloperidol |
| P769 | significant drug interaction | ... | Q421930 (mirtazapine) | mirtazapine |
| P769 | significant drug interaction | ... | Q422229 (diltiazem) | diltiazem |
| P769 | significant drug interaction | ... | Q423292 (paliperidone) | paliperidone |
| P769 | significant drug interaction | ... | Q423364 (propranolol) | propranolol |
| P769 | significant drug interaction | ... | Q423498 (trimipramine) | trimipramine |
| P769 | significant drug interaction | ... | Q407972 (chlorpromazine) | chlorpromazine |
| P769 | significant drug interaction | ... | Q408556 (levobunolol) | levobunolol |
| P769 | significant drug interaction | ... | Q409468 ((RS)-metoprolol) | (RS)-metoprolol |
| P769 | significant drug interaction | ... | Q424952 (nadolol) | nadolol |
| P769 | significant drug interaction | ... | Q71704041 ((E/Z)-doxepin) | (E/Z)-doxepin |
| P769 | significant drug interaction | ... | Q794162 (betaxolol) | betaxolol |
| P769 | significant drug interaction | ... | Q958087 (labetalol) | labetalol |
| P769 | significant drug interaction | ... | Q5186964 (crizotinib) | crizotinib |
| P9989 | stylized name | String | cloNIDine | ??? |
| P279 | subclass of | ... | Q11173 (chemical compound) | chemical compound |
| P2868 | subject has role | ... | Q575890 (antihypertensive drug) | antihypertensive drug |
| P2868 | subject has role | ... | Q173235 (analgesic) | analgesic |
| P2868 | subject has role | ... | Q1752522 (Sympatholytic) | Sympatholytic |
| P2868 | subject has role | ... | Q50430364 (Adrenergic alpha-2 Receptor Agonists) | Adrenergic alpha-2 Receptor Agonists |
Why not click here or view trends?
log id: 2190163